197 related articles for article (PubMed ID: 18094556)
1. [Clinical usefulness of plasma interleukin-6 and interleukin-10 in disseminated intravascular coagulation].
Seo JW; Kim HK; Lee DS; Cho HI
Korean J Lab Med; 2007 Apr; 27(2):83-8. PubMed ID: 18094556
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of 4 methods for outcome prediction in overt disseminated intravascular coagulation in dogs (2009-2014): 804 cases.
Goggs R; Mastrocco A; Brooks MB
J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):541-550. PubMed ID: 30302935
[TBL] [Abstract][Full Text] [Related]
5. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
6. Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation.
Chung S; Kim JE; Kim JY; Lee DS; Han KS; Kim HK
Thromb Res; 2010 Jun; 125(6):e285-93. PubMed ID: 20185166
[TBL] [Abstract][Full Text] [Related]
7. Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation.
Wada H; Sase T; Matsumoto T; Kushiya F; Sakakura M; Mori Y; Nishikawa M; Ohnishi K; Nakatani K; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2003 Jul; 9(3):233-40. PubMed ID: 14507112
[TBL] [Abstract][Full Text] [Related]
8. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
Egi M; Morimatsu H; Wiedermann CJ; Tani M; Kanazawa T; Suzuki S; Matsusaki T; Shimizu K; Toda Y; Iwasaki T; Morita K
Thromb Haemost; 2009 Apr; 101(4):696-705. PubMed ID: 19350114
[TBL] [Abstract][Full Text] [Related]
9. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.
Dempfle CE; Wurst M; Smolinski M; Lorenz S; Osika A; Olenik D; Fiedler F; Borggrefe M
Thromb Haemost; 2004 Apr; 91(4):812-8. PubMed ID: 15045145
[TBL] [Abstract][Full Text] [Related]
10. Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation.
Zheng X; Chen S; Zhang F; Ye M; Chen J; Zhang S
Blood Coagul Fibrinolysis; 2021 Jun; 32(4):248-252. PubMed ID: 33955858
[TBL] [Abstract][Full Text] [Related]
11. Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality.
Iba T; Arakawa M; Di Nisio M; Gando S; Anan H; Sato K; Ueki Y; Levy JH; Thachil J
J Intensive Care Med; 2020 Jul; 35(7):643-649. PubMed ID: 29720054
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Diagnostic Performance of Fibrin Monomer in Comparison to d-Dimer in Patients With Overt and Nonovert Disseminated Intravascular Coagulation.
Singh N; Pati HP; Tyagi S; Upadhyay AD; Saxena R
Clin Appl Thromb Hemost; 2017 Jul; 23(5):460-465. PubMed ID: 26574574
[TBL] [Abstract][Full Text] [Related]
13. Plasma factor XIII activity in patients with disseminated intravascular coagulation.
Song JW; Choi JR; Song KS; Rhee JH
Yonsei Med J; 2006 Apr; 47(2):196-200. PubMed ID: 16642548
[TBL] [Abstract][Full Text] [Related]
14. Modified score for disseminated intravascular coagulation in the critically ill.
Sivula M; Tallgren M; Pettilä V
Intensive Care Med; 2005 Sep; 31(9):1209-14. PubMed ID: 15959760
[TBL] [Abstract][Full Text] [Related]
15. Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation.
Kim HK; Lee DS; Kang SH; Kim JQ; Park S; Cho HI
Acta Haematol; 2007; 117(1):34-9. PubMed ID: 17095857
[TBL] [Abstract][Full Text] [Related]
16. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of DNA-histone complex and dsDNA are independent prognostic factors of disseminated intravascular coagulation.
Kim JE; Lee N; Gu JY; Yoo HJ; Kim HK
Thromb Res; 2015 Jun; 135(6):1064-9. PubMed ID: 25843168
[TBL] [Abstract][Full Text] [Related]
18. Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC.
Wada H; Hatada T; Okamoto K; Uchiyama T; Kawasugi K; Mayumi T; Gando S; Kushimoto S; Seki Y; Madoiwa S; Okamura T; Toh CH;
Am J Hematol; 2010 Sep; 85(9):691-4. PubMed ID: 20645433
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis.
Oh D; Jang MJ; Lee SJ; Chong SY; Kang MS; Wada H
Thromb Res; 2010 Jul; 126(1):18-23. PubMed ID: 20079919
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the cutoff values in fibrin-related markers for the diagnosis of overt DIC.
Hatada T; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Seki Y; Okamura T; Imai H; Kaneko T; Nobori T;
Clin Appl Thromb Hemost; 2012 Sep; 18(5):495-500. PubMed ID: 22203032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]